Logo for Valneva SE

Valneva Investor Relations Material

Latest events

Logo for Valneva SE

Q1 2025

Valneva
Logo for Valneva

Q1 2025

7 May, 2025
Logo for Valneva

Study Update

1 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Valneva SE

Access all reports
Valneva SE is a specialty vaccine company focused on developing and commercializing vaccines for infectious diseases. It targets diseases with significant unmet medical needs through proprietary and partnered programs. The company is headquartered in Saint-Herblain, France, and its shares are listed on the Euronext Paris.